# Ernexa Therapeutics Inc.: Form 8-K, filed Sep 25, 2024

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2024-09-25
- Accepted by EDGAR: Sep 25, 2024, 16:36 ET
- Period: 2024-09-24
- Accession: 0001493152-24-038129
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315224038129/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315224038129/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315224038129/form8-k.htm

Filed Sep 25, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-038129. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.